Federal contract award
36C25925F0172
PHARMACY ADVATE ANTIHEMOPHILIC FACTOR,RECOMBINANT 2000UNT/VIL INJ
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Veterans Affairs |
| Office | NETWORK CONTRACT OFFICE 19 (36C259) |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | V797D50492 |
| Set-aside | Not reported |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $10.8K |
| Current contract value | $10.8K |
| Potential contract value / ceiling | $10.8K |
| Start date | Jan 15, 2025 |
| Current end date | Jan 17, 2025 |
| Potential end date | Jan 17, 2025 |
| Latest award activity | Aug 19, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 19, 2025 | P00001 | $-5.4K | PHARMACY ADVATE ANTIHEMOPHILIC FACTOR,RECOMBINANT 2000UNT/VIL INJ |
| Jan 15, 2025 | 0 | $16.2K | PHARMACY ADVATE ANTIHEMOPHILIC FACTOR,RECOMBINANT 2000UNT/VIL INJ |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.